|

Trabedersen Clinical Trials

1 actively recruiting trial across 1 location

Also known as: OT101

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Nebraska1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Omaha, Nebraska1 trial

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

University of Nebraska Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.